Basic Information
Biocomposites focuses on developing innovative calcium compounds for surgical procedures. Their bone graft matrices can be used for bone regeneration in cases of infection and for managing dead space in a range of orthopedic surgeries. The company sells directly to hospitals and through independent distributors, with the United States representing its largest market.
Biocomposites Ltd
England,United Kingdom
51~100 people
January 01, 1996
jpanetta@biocom.org

